Coriell Institute for Medical Research
Coriell Institute of Medical Research
  • Request a Quote
  • Donate
  • Login
  • View Cart
Sample Catalog | Custom Services | Core Facilities | Genomic Data Search
  • Biobank
    • NIGMS
    • NINDS
    • NIA
    • NHGRI
    • NEI
    • Allen Cell Collection
    • Rett Syndrome iPSC Collection
    • Autism Research Resource
    • HD Community Biorepository
    • CDC Cell and DNA
    • J. Craig Venter Institute
    • Orphan Disease Center Collection
    • All Biobanks
  • Research
    • Overview
    • Meet Our Scientists
      • Our Faculty
      • Our Scientific Staff
    • Camden Cancer Research Center
    • Epigenetic Therapies SPORE
    • Core Facilities
    • Epigenomics
    • Camden Opioid Research Initiative (CORI)
    • The Issa & Jelinek Lab
    • The Jian Huang Lab
    • The Luke Chen Lab
      • The Lab
      • The Team
      • Publications
    • The Scheinfeldt Lab
    • The Shumei Song Lab
    • The Nora Engel Lab
      • The Lab
      • The Team
      • Publications
    • Publications
  • Services
    • Overview
    • Biobanking Services
      • Core Services
      • Project Management
      • Research Support Services
      • Sample Cataloging
      • Sample Collection Kits
      • Sample Data Management
      • Sample Distribution
      • Sample Management
      • Sample Procurement
      • Sample Storage
    • Bioinformatics and Biostatistics Services
    • Cellular and Molecular Services
      • Biomarker Research Solutions
      • Cell Culture
      • Nucleic Acid Isolation and Quality Control
    • Clinical Trial Support
      • Overview
      • Sample Collection
      • Data Management
      • Sample Processing and QC
      • Storage and Distribution
      • Biomarker Services
      • Data Analaysis
    • Core Facilties
      • Overview
      • Animal and Xenograft
      • Bioinformatics and Biostatistics
      • Cell Imaging
      • CRISPR Gene Engineering
      • Flow Cytometry and Cell Sorting
      • Genomics and Epigenomics
      • iPSC - Induced Pluripotent Stem Cells
      • Organoids
    • Coriell Marketplace
    • Genomic, Epigenomic and Multiomics Services
    • Stem Cells and iPSC Services
      • Core Services
      • Reprogramming
      • Characterization and Quality Control
      • Differentiated Cell Lines
      • iPSC-Derived Organoids
      • iPSC Expansion
      • iPSC Gene Editing
  • Ordering
    • Stem Cells
    • Cell Lines
    • DNA and RNA
    • Featured Products
      • FFPE
      • HMW DNA
    • Genomic Data Search
    • Search by Catalog ID
    • Help
      • Create Account
      • Order Online
      • Ordering FAQ
      • FAQs/Culture Instructions
      • Reference Materials
        • Biobanks
        • NIGMS Repository
        • NHGRI Repository
        • NINDS Repository
        • NIA Repository
        • NIST
        • GeT-RM
      • Secondary Distribution Policies
      • MTA Assurance Form
      • Shipment Policy
      • Contact Customer Service
  • About Us
    • Our History
    • Meet Our Team
    • Meet Our Board
    • Education
      • Science Fair
      • Summer Experience
      • Outreach
      • Research Program Internship
    • Press Room
      • Press Releases
      • Coriell Blog
      • Annual Report
    • Careers
      • Working at Coriell
    • Giving
      • Donate
      • Giving FAQ
    • Contact Us
    • Legal Notice
  • Login View Cart
search submit
GM25952 Fibroblast from Skin, Skin

Description:

MENTAL RETARDATION, X-LINKED 102; MRX102
DEAD/H BOX 3, X-LINKED; DDX3X

Affected:

Yes

Sex:

Female

Age:

10 YR (At Sampling)

  • Overview
  • Characterizations
  • Phenotypic Data
  • Publications
  • External Links
  • Culture Protocols

Overview

back to top
Repository NIGMS Human Genetic Cell Repository
Subcollection Heritable Diseases
PIGI Consented Sample
Biopsy Source Skin
Cell Type Fibroblast
Tissue Type Skin
Transformant Untransformed
Sample Source Fibroblast from Skin, Skin
Race White
Ethnicity Not Hispanic/Latino
Country of Origin USA
Family Member 1
Family History N
Relation to Proband proband
Species Homo sapiens
Common Name Human
Remarks Clinically affected; symptom onset at 6 months; diagnosed at age 9 years; breech presentation, labor induced at 37.5 weeks; birth measurements: weight 3.04 kg, length 51 cm, occipitofrontal circumference 34.5 cm; admitted 4 days for spontaneous pneumothorax; extreme irritability noted in first six months of life; recurrent middle ear effusion-otitis (12 ear infections reported between ages 2 and 3); hypotonia; rolled at 6 months; sat up at 12 months; crawled at 12 months; stood/cruised at 14 months; walked alone at 18 months; global developmental delay; delayed receptive and expressive language; moderate intellectual disability; first words 18 months; 3-4 word sentences by 34 months; by age 36 months naming colors 60% correct, animal sounds, and counting; estimated mental age/DQ of 0.6 (functioning at the level of a 5-6 year old at age 9); can perform some complex tasks and has islands of comprehension and expressive language; strong social attachments, reciprocal and some imaginative play; normal pointing; good adaptive function; attention deficit disorder; brain MRI detected prominence of temporal horns L>R; whole exome sequencing revealed subject is heterozygous for de novo Q417P (CAG>CCG): c.1250 A>C variant in exon 12 of the DDX3X gene; karyotype and Signature Genomics 3.0 BAC array were normal; surgery: myringotomy tubes; medications/supplements: Methylphenidate Hydrochloride (Concerta), Levothyroxine Sodium (Levo-T), probiotic; subject’s parents and three siblings do not harbor the Q417P variant in the DDX3X gene; unaffected mother is GM25953; subject is "Individual 30" in the publication by Snijders Blok, et al (PMID 26235985).

Characterizations

back to top
PDL at Freeze 6.9
Passage Frozen 3
 
IDENTIFICATION OF SPECIES OF ORIGIN Species of Origin Confirmed by LINE assay
 
Gene DDX3X
Chromosomal Location Xp11.4
Allelic Variant 1 p.Q417P; Mental retardation, X-linked 102
Identified Mutation c.1250 A>C; In 3 unrelated girls with X-linked mental retardation-102 (MRX102; 300958), Snijders Blok et al. (2015) identified a de novo heterozygous c.1126C-T transition (c.1126C-T, NM_001356.4) in the DDX3X gene, resulting in an arg376-to-cys (R376C) substitution in the helicase ATP-binding domain. The mutations were found by whole-exome sequencing of several large cohorts of patients with intellectual disability; R376C was not found in the ExAC or Exome Variant Server databases. In vitro cellular functional expression studies and in vivo studies in zebrafish indicated that the R376C mutation caused a loss of protein function, consistent with haploinsufficiency

Phenotypic Data

back to top
Remarks Clinically affected; symptom onset at 6 months; diagnosed at age 9 years; breech presentation, labor induced at 37.5 weeks; birth measurements: weight 3.04 kg, length 51 cm, occipitofrontal circumference 34.5 cm; admitted 4 days for spontaneous pneumothorax; extreme irritability noted in first six months of life; recurrent middle ear effusion-otitis (12 ear infections reported between ages 2 and 3); hypotonia; rolled at 6 months; sat up at 12 months; crawled at 12 months; stood/cruised at 14 months; walked alone at 18 months; global developmental delay; delayed receptive and expressive language; moderate intellectual disability; first words 18 months; 3-4 word sentences by 34 months; by age 36 months naming colors 60% correct, animal sounds, and counting; estimated mental age/DQ of 0.6 (functioning at the level of a 5-6 year old at age 9); can perform some complex tasks and has islands of comprehension and expressive language; strong social attachments, reciprocal and some imaginative play; normal pointing; good adaptive function; attention deficit disorder; brain MRI detected prominence of temporal horns L>R; whole exome sequencing revealed subject is heterozygous for de novo Q417P (CAG>CCG): c.1250 A>C variant in exon 12 of the DDX3X gene; karyotype and Signature Genomics 3.0 BAC array were normal; surgery: myringotomy tubes; medications/supplements: Methylphenidate Hydrochloride (Concerta), Levothyroxine Sodium (Levo-T), probiotic; subject’s parents and three siblings do not harbor the Q417P variant in the DDX3X gene; unaffected mother is GM25953; subject is "Individual 30" in the publication by Snijders Blok, et al (PMID 26235985).

Publications

back to top
Snijders Blok L, Madsen E, Juusola J, Gilissen C, Baralle D, Reijnders MR, Venselaar H, Helsmoortel C, Cho MT, Hoischen A, Vissers LE, Koemans TS, Wissink-Lindhout W, Eichler EE, Romano C, Van Esch H, Stumpel C, Vreeburg M, Smeets E, Oberndorff K, van Bon BW, Shaw M, Gecz J, Haan E, Bienek M, Jensen C, Loeys BL, Van Dijck A, Innes AM, Racher H, Vermeer S, Di Donato N, Rump A, Tatton-Brown K, Parker MJ, Henderson A, Lynch SA, Fryer A, Ross A, Vasudevan P, Kini U, Newbury-Ecob R, Chandler K, Male A, DDD Study A, Dijkstra S, Schieving J, Giltay J, van Gassen KL, Schuurs-Hoeijmakers J, Tan PL, Pediaditakis I, Haas SA, Retterer K, Reed P, Monaghan KG, Haverfield E, Natowicz M, Myers A, Kruer MC, Stein Q, Strauss KA, Brigatti KW, Keating K, Burton BK, Kim KH, Charrow J, Norman J, Foster-Barber A, Kline AD, Kimball A, Zackai E, Harr M, Fox J, McLaughlin J, Lindstrom K, Haude KM, van Roozendaal K, Brunner H, Chung WK, Kooy RF, Pfundt R, Kalscheuer V, Mehta SG, Katsanis N, Kleefstra T, Mutations in DDX3X Are a Common Cause of Unexplained Intellectual Disability with Gender-Specific Effects on Wnt Signaling American journal of human genetics97:343-52 2015
PubMed ID: 26235985

External Links

back to top
Gene Cards DDX3X
Gene Ontology GO:0003677 DNA binding
GO:0003723 RNA binding
GO:0004004 ATP-dependent RNA helicase activity
GO:0005524 ATP binding
NCBI Gene Gene ID:1654
NCBI GTR 300160 DEAD-BOX HELICASE 3, X-LINKED; DDX3X
300958 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE; MRXSSB
OMIM 300160 DEAD-BOX HELICASE 3, X-LINKED; DDX3X
300958 INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, SNIJDERS BLOK TYPE; MRXSSB

Culture Protocols

back to top
Cumulative PDL at Freeze 6.9
Passage Frozen 3
Split Ratio 1:6
Temperature 37 C
Percent CO2 5%
Percent O2 3%
Medium Eagles Minimum Essential Medium with Earle's salts:Dulbecco's modified MEM with 2mM L-glutamine or equivalent
Serum 15% fetal bovine serum Not inactivated
Substrate None specified
Supplement -
Pricing
International/Commercial/For-profit:
$373.00USD
U.S. Academic/Non-profit/Government:
$216.00USD
Add to Cart
How to Order
  • Ordering Instructions
  • MTA / Assurance Form
  • Statement of Research Intent Form
Related Products
Same Family
  • 3325
Miscellaneous
  • DNA on Demand
  • Custom Services

Our mission is to prevent and cure disease through biomedical research.

CONTACT US

CUSTOMER SERVICE
customerservice@coriell.org (800) 752-3805 • (856) 757-4848
Subscribe to our newsletter here

Coriell Institute for Medical Research
403 Haddon Avenue Camden, NJ 08103, USA (856) 966-7377

Ⓒ 2025 Coriell Institute. All rights reserved.

  • Facebook
  • Linkedin
  • Youtube